Antiplatelet Therapy Aims and Strategies in Asian Patients with Acute Coronary Syndrome or Stable Coronary Artery Disease

Dual antiplatelet therapy (DAPT) has been the mainstay treatment to reduce ischemic events, such as myocardial infarction or stroke, in patients with coronary artery disease (CAD). The development of potent P2Y(12) inhibitors (ticagrelor and prasugrel) has helped to further reduce ischemic events, p...

Descripción completa

Detalles Bibliográficos
Autores principales: Tam, Chor-Cheung, Tse, Hung-Fat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784545/
https://www.ncbi.nlm.nih.gov/pubmed/36556067
http://dx.doi.org/10.3390/jcm11247440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784545/
https://www.ncbi.nlm.nih.gov/pubmed/36556067
http://dx.doi.org/10.3390/jcm11247440

Ejemplares similares